NOVARTIS has a total of 15 patent applications. Its first patent ever was published in 1997. It filed its patents most often in South Africa, United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are H LUNDBECK A, HANMI PHARMACEUTICAL CO LTD and BRISTOL MYERS SQUIBB COMPANY UNA CORPORACION DEL ESTADO DE DELAWARE.
# | Country | Total Patents | |
---|---|---|---|
#1 | South Africa | 5 | |
#2 | United States | 3 | |
#3 | China | 2 | |
#4 | Morocco | 2 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Honduras | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers | |
#5 | Environmental technology | |
#6 | Measurement | |
#7 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Fairhurst Robin Alec | 2 |
#2 | Shafer Cynthia M | 1 |
#3 | Meredith E | 1 |
#4 | Bhardwaj Upkar | 1 |
#5 | Erb Bernhard | 1 |
#6 | Caplan Shari L | 1 |
#7 | Gregori Silvia Adriana | 1 |
#8 | Thangavelu Karthinathan | 1 |
#9 | Lai Xinzhong | 1 |
#10 | Edwards Lee | 1 |
Publication | Filing date | Title |
---|---|---|
ZA200308590B | Dipeptide derivatives having a n-terminal 2-thiocyl group as vasopeptidase inhibitors. | |
US6980842B2 | Ocular analyte sensor | |
US6900367B2 | Transgenic Drosophila melanogaster expressing a β42 in the eye | |
US6833241B2 | Mammary gland chemokine |